work to lower prescription costs

Robert Menendez · New Jersey · Democratic

policy impact 3.00 specificity 3.00 extraction confidence 98%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Occurrences

I’m working to lower prescription costs

The candidate commits to reducing prescription drug costs.

Menendez airs first TV ad
campaign · campaign_ad · model gpt-5.4-mini

To make life more affordable, my first bill was lowering prescription costs and increasing childcare tax credits.

The candidate reiterates support for lowering prescription costs.

Menendez for Congress Campaign Launches New Cable Ad “Scared” - Rob Menendez
campaign · other · model gpt-5.4-mini

Americans have rightly demanded lower costs for prescription drugs, and our pricing transparency bill aims to do just that.

Menendez says the transparency bill is intended to lower prescription drug costs by increasing pricing transparency.

Rep. Rob Menendez Introduces Bill to Increase Transparency of Prescription Drug Prices | U.S. House Representative Rob Menendez
primary · press_release · model gpt-5.4-mini

Expand access to affordable healthcare by lowering prescription drug prices, supporting community health centers, and strengthening protections for individuals with pre-existing conditions

Commits to lowering prescription drug prices as part of broader healthcare affordability efforts.

Affordability - Rob Menendez
campaign · campaign_site · model gpt-5.4-mini

Evidence

legacy_unverified · Source version not recorded · locator unknown

"To make life more affordable, my first bill was lowering prescription costs and increasing childcare tax credits."

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Campaign material states Menendez’s first bill was aimed at lowering prescription costs, showing the promise was explicitly adopted as a campaign message.

partial same_term

Menendez for Congress Campaign Launches New Cable Ad “Scared” - Rob Menendez
campaign · model gpt-5.4-mini · confidence 92%

legacy_unverified · Source version not recorded · locator unknown

Sponsor page shows the bill was introduced and referred on 03/27/2025; tracker status is Introduced.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Menendez joined a House bill intended to increase oversight of PBMs and lower prescription-drug costs, but Congress.gov shows no progress beyond introduction and referral.

never same_term A for effort

H.R. 2450 - Prescription Drug Transparency and Affordability Act - All Information
secondary · model gpt-5.4-mini · confidence 97%

legacy_unverified · Source version not recorded · locator unknown

Menendez said the bill would "increase transparency" in prescription drug pricing and "result in savings for patients and employers."

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The House office described concrete legislative action by Menendez to address prescription drug affordability, even though the bill did not advance into law.

partial same_term A for effort

Rep. Rob Menendez Introduces Bill to Increase Transparency of Prescription Drug Prices | U.S. House Representative Rob Menendez
primary · model gpt-5.4-mini · confidence 94%

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): never. same_term A for effort

Menendez did take concrete action to address prescription costs by making it a campaign priority and introducing H.R. 2450 to increase transparency and affordability, but the bill did not advance beyond introduction and referral. That is a serious legislative attempt, not a fulfilled outcome, so the promise is best rated as never delivered with effort credit.

provider codex_cli · model gpt-5.4-mini · confidence 97%

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): partial. same_term A for effort

Menendez took concrete same-term legislative action by introducing or sponsoring prescription-drug affordability legislation aimed at PBM transparency and patient savings. However, the cited bill remained only introduced/referred and there is no evidence that it became law or produced actual prescription-cost reductions. Because the promise was framed as working to lower costs rather than guaranteeing enacted reductions, this is best rated partial rather than never.

provider codex_cli · model gpt-5.5 · confidence 90%